Many Smartphone Apps Lack Privacy Policies

"California's attorney general filed a first-ever privacy lawsuit against the maker of a smartphone application, a move that could shape how the nascent app...

Are Today’s Social Media Sites Helpful in Managing Chronic Diseases Like Diabetes?

In an "Open letter to NPR about Diabetes Social Media piece," Kerri Morrone Sparling of Six Until Me, attempts to refute a claim made...

What’s at Stake in the Off-Label Promotion Debate: It’s NOT Free Speech!

In case you haven't heard, in a 2-to-1 split decision, the 2nd U.S. Circuit Court of Appeals in New York on Monday threw out...

Google’s NEW Rx Drug Search Results Page Raises Question: Will It Spur New, Favorable...

Last year I posted data that showed Google's OneBox Rx "Ads" steal clicks from organic branded Rx search results (see chart below). I just learned...

Is Online Pharma Advertising ROI Scalable? Outsize Results on Modest Spends May Not Scale...

At the recent 6th Annual Digital Pharma East conference in Philadelphia, Bill Drummy, CEO of HeartBeat Ideas, argued that 'With digital you can get way more bang for your buck, so you HAVE to think of the digital channel.' Drummy's message was simple: the ROI of online promotion is an order of magnitude greater than the "typical" 2:1 ROI for non-digital channel promotion. This may be true of small budget campiagns, but is it scaleable to the point where digital promotion gives you a significant bump in sales?

The Role of Social Media in Managaing Chronic Diseases

The Role of Social Media in Managaing Chronic Diseases Focus on Diabetes and ObesityIn an "Open letter...

The Role of Social Media in Managing Chronic Diseases: Focus on Diabetes and Obesity

On the one hand, there's the physician who's looking for 'evidence' that diabetes is being managed. On the other hand is the patient argument that 'emotional support' is also a key benefit. One could argue that BOTH sides have merit.

What’s at Stake in the Off-Label Debate

What's at Stake in the Off-Label Debate Freedom of speech may be the legal issue, but enhancing...

What’s at Stake in the Off-Label Debate: Freedom of speech may be the legal...

There are enough legal issues in this case to keep a boatload of constitutional and pharma lawyers busy for years. But let's look at this from a different perspective -- i.e., what pharma has to gain from this and what patients have to lose.

Google’s New Drug Search Result Format: A “Knowledge Graph” that doesn’t include pharma!

Google launched a new drug search result format that includes data from the U.S. FDA, the National Library of Medicine, and the Department of Veterans Affairs, among othersbut apparently not directly from pharmaceutical companies.